Literature DB >> 22515429

Ianthelliformisamines A-C, antibacterial bromotyrosine-derived metabolites from the marine sponge Suberea ianthelliformis.

Min Xu1, Rohan A Davis, Yunjiang Feng, Melissa L Sykes, Todd Shelper, Vicky M Avery, David Camp, Ronald J Quinn.   

Abstract

A high-throughput screening campaign using a prefractionated natural product library and an in vitro Pseudomonas aeruginosa (PAO200 strain) assay identified two antibacterial fractions derived from the marine sponge Suberea ianthelliformis. Mass-directed isolation of the CH(2)Cl(2)/CH(3)OH extract from S. ianthelliformis resulted in the purification of three new bromotyrosine-derived metabolites, ianthelliformisamines A-C (1-3), together with the known natural products aplysamine 1 (4) and araplysillin I (5). The structures of 1-3 were determined following analysis of 1D and 2D NMR and MS spectroscopic data. This is the first report of chemistry from the marine sponge S. ianthelliformis. Ianthelliformisamine A (1) showed inhibitory activity against the Gram-negative bacterium P. aeruginosa with an IC(50) value of 6.8 μM (MIC = 35 μM).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515429     DOI: 10.1021/np300147d

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  7 in total

Review 1.  Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials.

Authors:  Alka Choudhary; Lynn M Naughton; Itxaso Montánchez; Alan D W Dobson; Dilip K Rai
Journal:  Mar Drugs       Date:  2017-08-28       Impact factor: 5.118

2.  Bioactive Bromotyrosine-Derived Alkaloids from the Polynesian Sponge Suberea ianthelliformis.

Authors:  Amr El-Demerdash; Céline Moriou; Jordan Toullec; Marc Besson; Stéphanie Soulet; Nelly Schmitt; Sylvain Petek; David Lecchini; Cécile Debitus; Ali Al-Mourabit
Journal:  Mar Drugs       Date:  2018-04-27       Impact factor: 5.118

Review 3.  Marine Pharmacology in 2012-2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2017-08-29       Impact factor: 5.118

4.  Quorum Sensing Inhibitory and Antifouling Activities of New Bromotyrosine Metabolites from the Polynesian Sponge Pseudoceratina n. sp.

Authors:  Florent Tintillier; Céline Moriou; Sylvain Petek; Marilyne Fauchon; Claire Hellio; Denis Saulnier; Merrick Ekins; John N A Hooper; Ali Al-Mourabit; Cécile Debitus
Journal:  Mar Drugs       Date:  2020-05-21       Impact factor: 5.118

5.  Application of Networking Approaches to Assess the Chemical Diversity, Biogeography, and Pharmaceutical Potential of Verongiida Natural Products.

Authors:  James Lever; Robert Brkljača; Colin Rix; Sylvia Urban
Journal:  Mar Drugs       Date:  2021-10-18       Impact factor: 5.118

6.  Targeted Isolation of Antibiotic Brominated Alkaloids from the Marine Sponge Pseudoceratina durissima Using Virtual Screening and Molecular Networking.

Authors:  James Lever; Florian Kreuder; Jason Henry; Andrew Hung; Pierre-Marie Allard; Robert Brkljača; Colin Rix; Aya C Taki; Robin B Gasser; Jan Kaslin; Donald Wlodkowic; Jean-Luc Wolfender; Sylvia Urban
Journal:  Mar Drugs       Date:  2022-08-29       Impact factor: 6.085

7.  Natural product polyamines that inhibit human carbonic anhydrases.

Authors:  Rohan A Davis; Daniela Vullo; Claudiu T Supuran; Sally-Ann Poulsen
Journal:  Biomed Res Int       Date:  2014-08-05       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.